Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
IF
IHC
Concentration
1 mg/ml
Recomended Dilution
Immunohistochemistry: 1/100 - 1/300. ELISA: 1/40000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human PLA2G4E. AA range:401-450
Subcellular Location
Cytoplasm, cytosol . Early endosome membrane
Cytoplasmic side . Cell membrane
Cytoplasmic side . Lysosome membrane
Cytoplasmic side . Targeted to clathrin-independent endocytotic vesicles through binding to phosphoinositides, especially phosphatidylinositol 4,5-bisphosphates. .
Peripheral membrane protein
Peripheral membrane protein
Peripheral membrane protein
Cytoplasmic side . Cell membrane
Cytoplasmic side . Lysosome membrane
Cytoplasmic side . Targeted to clathrin-independent endocytotic vesicles through binding to phosphoinositides, especially phosphatidylinositol 4,5-bisphosphates. .
Peripheral membrane protein
Peripheral membrane protein
Peripheral membrane protein
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
123745
Other Name
Cytosolic phospholipase A2 epsilon
PLA2G4E
Phospholipase A2 group IVE
cPLA2-epsilon
PLA2G4E
Phospholipase A2 group IVE
cPLA2-epsilon
Background
catalytic activity:Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate.,domain:The N-terminal C2 domain associates with lipid membranes and mediates its regulation by presenting the active site to its substrate in response to elevati